SCHEMBL29387110

SCHEMBL29387110

CSCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)C(C)C

nearest known ligand 0.66

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 3/20 0.60
▸ CRHR1 P34998 1/20 0.56
▸ CRHR2 Q13324 1/20 0.56
▸ NPY2R P49146 7/20 0.56
▸ NPY4R P50391 7/20 0.56
▸ NPY5R Q15761 7/20 0.56
▸ NPY1R P25929 5/20 0.56
▸ OPRM1 P35372 2/20 0.54
▸ OPRD1 P41143 2/20 0.54
▸ OPRK1 P41145 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31232439 0.89 OPRM1 (0.63) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL38663746 0.88 CALCR (0.65) CALCRCRHR1CRHR2NPY2RNPY4R
SCHEMBL30567763 0.88 CALCR (0.73) CALCRCRHR1CRHR2NPY2RNPY4R
SCHEMBL31182922 0.88 CALCR (0.71) CALCRCRHR1CRHR2NPY2RNPY4R
SCHEMBL30176483 0.88 CALCR (0.66) CALCRCRHR1CRHR2NPY2RNPY4R
SCHEMBL31295738 0.88 TFPI (0.64) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL11662077 0.88 CALCR (0.67) CALCRCRHR1CRHR2NPY2RNPY4R
SCHEMBL30567759 0.88 CALCR (0.72) CALCRCRHR1CRHR2NPY2RNPY4R
SCHEMBL30432567 0.88 CALCR (0.68) CALCRCRHR1CRHR2NPY2RNPY4R
SCHEMBL31182662 0.87 NPY2R (0.68) CALCRNPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4338378-A1 AUTOMATED ADJUSTMENT SYSTEM FOR NON-LIGHT-EMITTING VARIABLE TRANSMISSION DEVICES AND A METHOD OF USING THE SAME Sage Electrochromics, Inc. (US) 2024-03-20 — — EP claimed
US-20230075520-A1 INSULATED GLAZING UNIT INCLUDING AN INTEGRATED ELECTRONICS MODULE SAGE ELECTROCHROMICS, INC. 2023-03-09 — — US claimed
WO-2022246430-A1 TRANSPARENT THERMOELECTRIC SELFPOWERED GLAZING SAGE ELECTROCHROMICS, INC. (US) 2022-11-24 — — WO claimed
WO-2022241462-A1 AUTOMATED ADJUSTMENT SYSTEM FOR NON-LIGHT-EMITTING VARIABLE TRANSMISSION DEVICES AND A METHOD OF USING THE SAME SAGE ELECTROCHROMICS, INC. (US) 2022-11-17 — — WO claimed
US-12479873-B2 Metal complexes UDC Ireland (IE) 2025-11-25 — — US disclosed
US-12148804-B2 Semiconductor device including one or more p-type semiconductors provided between an n-type semiconductor layer and an electrode FLOSFIA INC. (JP) 2024-11-19 — — US disclosed
US-20240279144-A1 CONTROL OF IODIDES IN ACETIC ACID PRODUCTION LYONDELLBASELL ACETYLS, LLC (US) 2024-08-22 — — US disclosed
EP-4338378-A1 AUTOMATED ADJUSTMENT SYSTEM FOR NON-LIGHT-EMITTING VARIABLE TRANSMISSION DEVICES AND A METHOD OF USING THE SAME Sage Electrochromics, Inc. (US) 2024-03-20 — — EP disclosed
EP-4305492-A1 SUPPORT SYSTEM FOR TRANSPARENT DEVICES Sage Electrochromics, Inc. (US) 2024-01-17 — — EP disclosed
EP-4291947-A1 CONTROLLED REFLECTANCE IN ELECTROCHROMIC DEVICES Sage Electrochromics, Inc. (US) 2023-12-20 — — EP disclosed
US-20230322826-A1 METAL COMPLEXES UDC IRELAND LIMITED (IE) 2023-10-12 — — US disclosed
US-11713332-B2 Metal complexes MERCK PATENT GMBH (DE) 2023-08-01 — — US disclosed
WO-2022192903-A1 SUPPORT SYSTEM FOR TRANSPARENT DEVICES SAGE ELECTROCHROMICS, INC. (US) 2022-09-15 — — WO disclosed
EP-4051817-A1 A METHOD OF RECOVERING IRIDIUM Syddansk Universitet (DK) 2022-09-07 — — EP disclosed
US-11437592-B2 Dinuclear and oligonuclear metal complexes containing tripodal bidentate part ligands and their use in electronic devices MERCK PATENT GMBH (DE) 2022-09-06 — — US disclosed
EP-4046369-A1 CONTROL SYSTEM FOR NON-LIGHT-EMITTING VARIABLE TRANSMISSION DEVICES AND A METHOD OF USING THE SAME Sage Electrochromics, Inc. (US) 2022-08-24 — — EP disclosed
WO-2022174225-A1 CONTROLLED REFLECTANCE IN ELECTROCHROMIC DEVICES SAGE ELECTROCHROMICS, INC. (US) 2022-08-18 — — WO disclosed
US-11404649-B2 Electroluminescent bridged metal complexes for use in electronic devices MERCK PATENT GMBH (DE) 2022-08-02 — — US disclosed
EP-4018258-A1 CONTROL METHODS AND SYSTEMS USING OUTSIDE TEMPERATURE AS A DRIVER FOR CHANGING WINDOW TINT STATES View, Inc. (US) 2022-06-29 — — EP disclosed
EP-3954037-A1 APPARATUS FOR OPERATING AN ELECTROACTIVE DEVICE AND A METHOD OF USING THE SAME Sage Electrochromics, Inc. (US) 2022-02-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12479873-B2 Metal complexes AP1M1, SOD1, AP3M1 CALCR 2094/4885CRHR1 4472/4885CRHR2 4275/4885
US-20240279144-A1 CONTROL OF IODIDES IN ACETIC ACID PRODUCTION CA5A, TST, CA5B CALCR 3858/4885CRHR1 4804/4885CRHR2 4816/4885
US-11404649-B2 Electroluminescent bridged metal complexes for use in electronic devices MCOLN2, MCOLN1, NCLN CALCR 2661/4885CRHR1 4361/4885CRHR2 3908/4885
US-11713332-B2 Metal complexes AP1M1, SOD1, AP3M1 CALCR 2094/4885CRHR1 4472/4885CRHR2 4275/4885
US-20230322826-A1 METAL COMPLEXES AP1M1, SOD1, AP3M1 CALCR 2094/4885CRHR1 4472/4885CRHR2 4275/4885
US-11437592-B2 Dinuclear and oligonuclear metal complexes containing tripodal bidentate part ligands and their use in electronic devices SSBP1, POLRMT, BICRA CALCR 827/4885CRHR1 3204/4885CRHR2 3705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback